AK155: A CANDIDATE GENE FOR INFLAMMATORY BOWEL DISEASE

被引：0
|
作者：
Jennings, J. S. R. [1 ]
Hamlin, J. [1 ]
Robinson, P. A. [2 ]
Hull, M. A. [3 ]
Howdle, P. O. [3 ]
Markham, A. F. [3 ]
机构：
[1] Leeds Gen Infirm, Dept Gastroenterol, Leeds, W Yorkshire, England
[2] Univ Leeds, Leeds Inst Mol Med, Leeds, W Yorkshire, England
[3] Leeds Gen Infirm, Leeds Inst Mol Med, Leeds, W Yorkshire, England
来源：
GUT | 2010年 / 59卷
关键词：
D O I：
10.1136/gut.2009.209072z
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A86 / A87
页数：2
相关论文
共 50 条
  • [41] Gene transfer approaches for the treatment of inflammatory bowel disease
    Wirtz, S
    Neurath, MF
    GENE THERAPY, 2003, 10 (10) : 854 - 860
  • [42] Quantitative lymphatic vessel trait analysis suggests Vcam1 as candidate modifier gene of inflammatory bowel disease
    Jurisic, G.
    Sundberg, J. P.
    Bleich, A.
    Leiter, E. H.
    Broman, K. W.
    Buechler, G.
    Alley, L.
    Vestweber, D.
    Detmar, M.
    GENES AND IMMUNITY, 2010, 11 (03) : 219 - 231
  • [43] Quantitative lymphatic vessel trait analysis suggests Vcam1 as candidate modifier gene of inflammatory bowel disease
    G Jurisic
    J P Sundberg
    A Bleich
    E H Leiter
    K W Broman
    G Buechler
    L Alley
    D Vestweber
    M Detmar
    Genes & Immunity, 2010, 11 : 219 - 231
  • [44] The interleukin-25 gene located in the inflammatory bowel disease (IBD) 4 region:: no association with inflammatory bowel disease
    Büning, C
    Genschel, J
    Weltrich, R
    Lochs, H
    Schmidt, H
    EUROPEAN JOURNAL OF IMMUNOGENETICS, 2003, 30 (05): : 329 - 333
  • [45] 20 kDa PEGylated Adrenomedullin as a New Therapeutic Candidate for Inflammatory Bowel Disease
    Miki, Goro
    Kuroishi, Nobuko
    Tokashiki, Mariko
    Nagata, Sayaka
    Tamura, Masaji
    Yoshiya, Taku
    Yoshizawa-Kumagaye, Kumiko
    Ashizuka, Shinya
    Kato, Joji
    Yamasaki, Motoo
    Kitamura, Kazuo
    GASTROINTESTINAL DISORDERS, 2020, 2 (04): : 366 - 377
  • [46] Novel drug candidate for the treatment of Inflammatory Bowel Disease with unique mechanisms of action
    Lee, J.
    Kim, G.
    Kim, J. C.
    Park, J. H.
    Han, C.
    Kim, M.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : I261 - I261
  • [47] Characterization of candidate genes in inflammatory bowel disease-associated risk loci
    Peloquin, Joanna M.
    Goel, Gautam
    Kong, Lingjia
    Huang, Hailiang
    Haritunians, Talin
    Sartor, R. Balfour
    Daly, Mark J.
    Newberry, Rodney D.
    McGovern, Dermot P.
    Yajnik, Vijay
    Lira, Sergio A.
    Xavier, Ramnik J.
    JCI INSIGHT, 2016, 1 (13):
  • [48] Candidate mucosal and surrogate biomarkers of inflammatory bowel disease in the era of new technology
    Florholmen, Jon
    Fries, Walter
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2011, 46 (12) : 1407 - 1417
  • [49] Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease
    Williams, Amanda D.
    Korolkova, Olga Y.
    Sakwe, Amos M.
    Geiger, Timothy M.
    James, Samuel D.
    Muldoon, Roberta L.
    Herline, Alan J.
    Goodwin, J. Shawn
    Izban, Michael G.
    Washington, Mary K.
    Smoot, Duane T.
    Ballard, Billy R.
    Gazouli, Maria
    M'Koma, Amosy E.
    PLOS ONE, 2017, 12 (08):
  • [50] Identification of candidate biomarkers for inflammatory bowel disease using a seldi proteinchip system
    Kanmura, Shull
    Uto, Hirofumi
    Numata, Masatsugu
    Toyama, Keiko
    Abe, Hiroo
    Miike, Tadashi
    Tahara, Yoshihiro
    Kodama, Mayumi
    Shimoda, Kazuya
    Tsubouchi, Hirohito
    GASTROENTEROLOGY, 2007, 132 (04) : A363 - A363
12345